A-Alpha Bio

A-Alpha Bio Accelerates Drug Development with Synthetic Biology and Next-Generation Sequencing. We are a team of synthetic biologists, next-generation sequencing experts, and computational biologists dedicated to discovering better drugs faster. The company has developed a proprietary platform technology called AlphaSeq, which uses genetically engineered yeast cells to experimentally measure millions of protein interaction affinities simultaneously at a library-vs-library scale, generating vast amounts of data to discover and develop effective, specific, and cross-reactive drugs.